Cholesterol-Reducing Ingredient Partners

In this case study, a biotechnology company engaged CPL Business Consultants to find commercialisation partners for a cholesterol-reducing ingredient. Through its extensive networks, CPL facilitated a strategic partnership to develop this nutraceutical product.

The client had isolated a saponin component from its plant bioreactor platform, which had cholesterol-lowering properties in humans. The client asked CPL to implement a go-to-market strategy from a previous engagement.

CPL identified potential partners to help develop a cholesterol-reducing nutraceutical ingredient for food and dietary supplements. The client sought a technically minded company with established sales and marketing, with the experience and resources required for process optimisation, clinical trials, formulation trials, product registration and regulatory approval.

Teaser

Initially, CPL developed a Teaser based on the work and IP position to date. The Teaser described the opportunity available in broad terms, including information on product utility, the desired outcome and the characteristics sought in a partner.

Next, through its knowledge of the food ingredients and dietary supplement industries, CPL made suitable companies aware of the opportunity. CPL then contacted target companies and talked through the opportunity and its technical, clinical and commercial validity. Contacts included meetings set up at industry events, for example, in the USA and Europe.

Information Memorandum

CPL then supplied the Information Memorandum to interested companies. The IM contained further information about the product, the clinical results and the market potential. As required, CPL talked through the IM with companies prior to meetings and discussions with the client.

CPL recommended which partners and business arrangements would suit the client’s strategic goals i.e. a best-fit approach.

Click to see the contents of the study, or otherwise, look below for an outline.